The effect of alpha-lipoic acid on blood pressure in type 2 diabetics

Iranian Journal of Endocrinology and Metabolism

Volumn 11, Issue 3, 2009, Pages

  Mazloom, Z ^a   Ansar, H ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

Alpha lipoic acid; Antioxidant; Blood pressure; Oxidative stress; Type 2 diabetes

Indexed keywords

EID: 73649083695     PISSN: 16834844     EISSN: 16835476     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Elliott WJ. Intensive antihypertensive treatment to the new lower blood pressure targets. Curr Hypertens Rep 1999;1:313-19.
2. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 1995;44: 363-8.
3. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium.Am J Physiol 1994; 266: H2568-72.
4. Jun T, Ke-yan F, Catalano M. Increased superoxide anion production in humans: a possible mechanism for the pathogenesis of hypertension. J Hum Hypertens 1996; 10: 305-9.
5. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19:257-67.
6. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993; 19: 59-66.
7. Mehta JL, Lopez LM, Chen L, Cox OE. Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol. Am J Cardiol 1994; 74: 901-5.
8. D.Ros R, Assaloni R, Ceriello A. Antioxidant therapy in diabetic complications: What is new?. Curr Vas Pharm 2004; 2:335-41.
9. Bonora E, Targher G, Alberiche M, Bonadonna RC, Zenere MB, Saggiani F,et al. Intracellular Partition of Plasma Glucose Disposal in Hypertensive and Normotensive Subjects with Type 2 Diabetes Mellitus. J Clin Endocrinol Metab 2001; 86: 2073-9.
10. Jarrett RJ. Cardiovascular disease and hypertension in diabetes mellitus. Diab Metab Rev 1989; 5: 547-58.
11. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998; 32: 59-64.
12. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993; 57: 650-6.
13. Kaul N, Siveski-Iliskovic N, Thomas TP, Hill M, Khaper N, Singal PK. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition 1995; 11 Suppl 5: 551-4.
14. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens 2000; 18: 567-73.
15. Packer L, Roy S, Sen CK. alpha-Lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. Adv Pharmacol 1999; 38:79-101.
16. Jacob S, Henriksen EJ, Tritschler HJ, Augustin HJ, Dietze GJ. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabetes 1996;104:284-8.
17. Jacob S, Streeper RS, Fogt DL, Hokama JY, Tritschler HJ, Dietze GJ, Henriksen EJ. The antioxidant --lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes1996; 45: 1024-9.
18. Heitzer T, Finckh B, Albers S, Krohn K, Kohlschütter A, Meinertz T. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxid-mediated vasodilation in diabetic paitient: relation to parameters of oxidative stress. Free Radic Biol Med 2001; 31:53-61.
19. Midaui AE, Elimadi A, Wu L, Haddad PS, de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and increases in heart mitochondrial superoxid production .Am J Hypertens 2003;16: 173-9.
20. Sarafidis PA, Bakris G L. Insulin and Endothelin: An Interplay Contributing to Hypertension Development? J Clin Endocrinol Metab 2007; 92:379-85.
21. Saad M F, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, et al. Insulin Resistance and Hypertension. Hypertension 2004;43:1324-31.
22. Vukkarasu T, Anitha Nandhini AT, Anuradha CV. Lipoic acid improves glucose utilization and prevents protein glycation and AGE formation. Pharmazie 2005; 60: 772-5.
23. Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, et al. Enhancement of glucose disposal in patients with Type 2 diabetes by alpha-lipoic acid. ArzneimittelForschung 1995; 45: 872-4.
24. Midaoui AE, Champlain JD. Prevention of hypertension, Insulin Resistance, and oxidative stress by Lipoic Acid . Hypertension 2002, 39: 303-7.
25. Borcea V, Nourooz-Zadeh J, Wolff SP, Klevesath M, Hofmann M, Urich H, et al. Alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med 1999; 26: 1495-500.
26. Hunt JV, Wolff SP. Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radic Res Commun 1991; 12-13 pt1:115-23.
27. Wagh SS, Natraj CV, Menon KKG. Mode of action of lipoic acid in diabetes. J Biosc 1987;11:59-74.